Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.

Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS, approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults, and AGGRASTAT a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Number of employees : 85 persons.
Sales per Businesses
20132014Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies4.65100%33.18100% +86%
Sales per Regions
20132014Delta
CAD (in Million)%CAD (in Million)%
Rest of World2.6957.9%17.3852.4% +84.51%
Europe1.9542%15.8047.6% +87.64%
Managers
NameAgeSinceTitle
William L. Hunter, MD522007President, Chief Executive Officer & Director
William James O'Shea662015Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald, CA-2006Chief Financial Officer
Harold H. Shlevin, PhD662004Independent Director
Richard M. Glickman, PhD562006Lead Independent Director
Mark H. N. Corrigan, MD582015Director
Arthur H. Willms762015Director
Robert James Meyer, MD-2015Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Shareholders
NameEquities%
Westfield Capital Management Co. LP 3,669,435 18.6%
Putnam Investment Management LLC 2,773,898 14.1%
Clough Capital Partners LP 1,734,083 8.81%
Rock Springs Capital Management LP 1,190,000 6.04%
Fidelity Management & Research Co. 816,582 4.15%
Turner Investments LP 693,122 3.52%
PointState Capital LP 600,000 3.05%
AlphaOne Investment Services LLC 576,468 2.93%
William L. Hunter, MD 560,000 2.84%
Adage Capital Management LP 500,000 2.54%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
CSL LIMITED
ALEXION PHARMACEU..
BAXALTA INC
GRIFOLS SA
CHONGQING ZHIFEI ..
-
WALVAX BIOTECHNOL..
-
JIANGXI BOYA BIO-..
ABCAM PLC
STAIDSON (BEIJING..
PROMETIC LIFE SCI..
ZHEJIANG WOLWO BI..
BIOTEST AG
LOXO ONCOLOGY INC
-
ESSEX BIO-TECHNOL..
-
CHIASMA INC
PEREGRINE PHARMAC..
ALTEOGEN INC
-
REPROCELL INCORPO..
-
VITAE PHARMACEUTI..
ADIMMUNE CORP
-
Sector Pharmaceuticals
Cardiome Pharma Corp : Connections
The Vancouver Symphony Foundation
ProStrakan Group Plc
viDA Therapeutics, Inc.
Michael Smith Foundation for Health Research
enGene, Inc.
Trevi Therapeutics, Inc.
Richardson Capital Ltd.
Premier's Technology Council
Pamlico BioPharma, Inc.
MedGenesis Therapeutix, Inc.
Synereca Pharmaceuticals, Inc.
Kearny Venture Partners
The Institute of Electrical & Electronics Engineers, Inc.
Licensing Executives Society
Quartet Medicine, Inc.
The American Physiological Society
Vancouver Symphony Orchestra
American Society for Pharmacology & Experimental Therapeutic
ATDC Seed Capital Fund LLC
British Columbia Lottery Corp.
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2016 People , Fundamentals and Ownership